Search

Displaying results 1 - 10 of 929 in total
  1. Drug

    Bupropion

    go.drugbank.com/drugs/DB01156
    ApprovedInvestigational

    [L6562] Studies have shown that the combined activity of bupropion and [naltrexone] increase the firing rate of hypothalamic pro-opiomelanocortin (POMC) neurons and blockade of opioid receptor-mediated … More specifically, bupropion binds to the norepinephrine transporter (NET) and the dopamine transporter (DAT).

    Synonyms: BupropionSalts: Bupropion hydrobromide, Bupropion hydrochloride
  2. Drug

    Obexelimab

    go.drugbank.com/drugs/DB15032
    Investigational

    Obexelimab is under investigation in clinical trial NCT02725515 (A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus).

    Synonyms: XMAB5871 (HUMANIZED ANTI-CD19 ANTIBODY WITH AN FC PORTION ENGINEERED FOR INCREASED AFFINITY (200- TO 400-FOLD OVER NATIVE IGG) TO FCGRIIB)
  3. Drug

    Rice bran oil

    go.drugbank.com/drugs/DB11293
    ApprovedInvestigational

    Rice bran oil is extracted from the hard outer brown layer of rice after chaff (rice husk) used for high-temperature cooking methods such as deep frying and stir frying. It contains monosaturated fatty acids, polyunsaturated fatty acids,...

    Products: Claritying turn over rice perfect oil foam cleanser
  4. Drug

    Avobenzone

    go.drugbank.com/drugs/DB09495
    ApprovedInvestigational

    Avobenzone has the ability to absorb ultraviolet light over wider range of wavelengths. It is included in many commercially available sunscreens which are used as wide spectrum sunscreens.

    Mixtures: Bobbi Brown All Over Bronzing Gel SPF 15, Exuviance Optilight All-Over Dark Spot Minimizer SPF 25Products: Leaders Sunbuddy All Over Sun
  5. Drug

    Mitomycin

    go.drugbank.com/drugs/DB00305
    ApprovedInvestigational

    [A193419] Mitomycin's cross-linking activity has resulted in its approval for the treatment of a variety of cancers - the most recent of which is an April 2020 approval for its use in low-grade Upper

    Products: Mitomycin Accord 10 mg Pulver zur Herstellung einer Injektions- / Infusionslösung oder Lösung zur intravesikalen Anwendung, Mitomycin Accord 2 mg Pulver zur Herstellung einer Injektions- / Infusionslösung oder Lösung zur intravesikalen Anwendung
  6. Drug

    Antithrombin III human

    go.drugbank.com/drugs/DB11598
    ApprovedInvestigational

    A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily.

    Products: . - Pulver und Lösungsmittel zur Herstellung einer Injektions- oder Infusionslösung, Pulver und Lösungsmittel zur Herstellung einer Injektions- oder Infusionslösung
  7. Drug

    Teicoplanin

    go.drugbank.com/drugs/DB06149
    ApprovedInvestigationalWithdrawn

    Teicoplanin is a glycopeptide antibiotic consisting of a mixture of several compounds, five major (named teicoplanin A2-1 through A2-5) and four minor (named teicoplanin RS-1 through RS-4). All teicoplanins share a same glycopeptide core...

    Products: Teicoplanin Mylan 100 mg Pulver zur Herstellung einer Injektions-/Infusionslösung oder einer Lösung zum Einnehmen, Teicoplanin Mylan 200 mg Pulver zur Herstellung einer Injektions-/Infusionslösung oder einer Lösung zum Einnehmen
  8. Drug

    Remifentanil

    go.drugbank.com/drugs/DB00899
    ApprovedInvestigational

    Remifentanil is a specific mu-type-opioid receptor agonist which means it reduces sympathetic nervous system tone, and causes respiratory depression and analgesia.

    Products: Remifentanil Kabi 1 mg Pulver zur Herstellung eines Konzentrats für eine Injektions- oder Infusionslösung, Remifentanil Kabi 2 mg Pulver zur Herstellung eines Konzentrats für eine Injektions- oder Infusionslösung
  9. Drug

    Abciximab

    go.drugbank.com/drugs/DB00054
    ApprovedWithdrawn

    It also binds to vitronectin (αvβ3) receptor found on platelets and vessel wall endothelial and smooth muscle cells. … Abciximab binds to the glycoprotein (GP) IIb/IIIa receptor of human platelets and inhibits platelet aggregation by preventing the binding of fibrinogen, von Willebrand factor, and other adhesive molecules

    Categories: Glycoprotein IIb/IIIa Receptor-directed Monoclonal AntibodiesProducts: ReoPro 2 mg/ml Injektionslösung oder Infusionslösung
  10. Drug

    Ferric derisomaltose

    go.drugbank.com/drugs/DB15617
    ApprovedInvestigational

    Iron deficiency is an extremely common condition and is the most frequent cause of anemia worldwide. Iron deficiency results when iron intake, iron stores, and loss of iron from the body do not adequately support production of erythrocyt...

    Products: Monofer 100 mg/ml Injektions- oder Infusionslösung